Description
Idelalisib, marketed under the brand name ZYDELIG, It is an prescription medication that has been approved idelalisib (Zydelig) on July 23, 2014 for the treatment of relapsed follicular lymphoma (FL) and small lymphocytic lymphoma (SLL).
What is ZYDELIG (idelalisib) ?
Zydelig is a kinase inhibitor indicated for the treatment of patients with:
Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities.
Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies.
Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies.
How to order approved “ZYDELIG (idelalisib) for tablets” Medicine?
ZYDELIG (Idelalisib) Tablet is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing ZYDELIG and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
